Expanding the Patient Pool for Rilonacept [PDF]
Recurrent pericarditis complicates 15%-30% of acute pericarditis cases despite initial anti-inflammatory treatment. The RHAPSODY trial (Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis) showed ...
Emma St. John, MD +9 more
doaj +4 more sources
Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS) [PDF]
Justin Gillespie, Rebeccah Mathews, Michael F McDermottNIHR-Leeds Musculoskeletal Biomedical Research Unit (NIHR-LMBRU), Leeds Institute of Molecular Medicine (LIMM), St.
Justin Gillespie +2 more
doaj +6 more sources
Recurrent Sterile Pleuropericarditis After Withdrawal of Renal Transplant Immunosuppression in Anuric ESRD: A Case of Suspected IL-1–Mediated Autoinflammation [PDF]
Recurrent pericarditis and serositis pose a significant diagnostic challenge in patients with end-stage renal disease (ESRD) and a history of extensive immunosuppression.
Evelien van Gelderen +2 more
doaj +3 more sources
Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis [PDF]
Ankit Agrawal +2 more
exaly +6 more sources
Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis [PDF]
Interleukin 1 (IL-1) has been indicated as a mediator of recurrent pericarditis. Rilonacept, a soluble IL-1 receptor chimeric fusion protein neutralizing interleukin 1 alpha (IL-1α) and interleukin 1 beta (IL-1β), has demonstrated promising results in a ...
Amen, Shwan +12 more
core +7 more sources
Mechanistic Insights and Emerging Therapeutic Strategies in Recurrent Pericarditis [PDF]
Recurrent pericarditis is a heterogeneous and often debilitating inflammatory disorder characterized by recurrent flares following a symptom-free interval of at least 4 to 6 weeks.
Mohammad A. Alqahtani +2 more
doaj +2 more sources
Objectives Several therapies are used for the treatment of rareautoinflammatory conditions like cryopyrin-associated periodic fever syndromes (CAPS), hyperimmunoglobulin Dsyndrome (HIDS)/mevalonate kinase deficiency (MKD) and tumour necrosis factor ...
Peter Hur +5 more
doaj +2 more sources
Background Recurrent pericarditis is an interleukin‐1–mediated chronic autoinflammatory disease. The phase 3 study RHAPSODY (Rilonacept Inhibition of IL‐1 Alpha and IL‐1 Beta for Recurrent Pericarditis: a Pivotal Symptomatology and Outcomes Study ...
Lucia Trotta +11 more
doaj +2 more sources
Interleukin-1 Blockade With Rilonacept in Recurrent Pericarditis: Tapering and Discontinuation in Real-World Practice. [PDF]
[Figure: see text]
Marchetta M +9 more
europepmc +3 more sources
Constrictive-effusive pericarditis as presenting feature of IgG4-related disease (IgG4-RD): a case report [PDF]
Background IgG4-Related Disease (IgG4-RD) is a fibroinflammatory disorder initially identified as autoimmune pancreatitis but subsequently shown in numerous other organs with common pathological hallmarks.
Robert Fekete
doaj +2 more sources

